Historical Stock Price
FPRX historical stock prices picture
FPRX (FPRX) has the following price history information. Looking back at FPRX historical stock prices for the last five trading days, on April 12, 2021, FPRX opened at $37.91, traded as high as $37.97 and as low as $37.91, and closed at $37.97. Trading volume was a total of 694.40K shares. On April 13, 2021, FPRX opened at $37.96, traded as high as $37.98 and as low as $37.94, and closed at $37.94. Trading volume was a total of 947.10K shares. On April 14, 2021, FPRX opened at $37.96, traded as high as $37.99 and as low as $37.94, and closed at $37.99. Trading volume was a total of 839.10K shares. On April 15, 2021, FPRX opened at $37.99, traded as high as $38.01 and as low as $37.95, and closed at $38.00. Trading volume was a total of 1.01M shares. On April 16, 2021, FPRX opened at $38.00, traded as high as $38.00 and as low as $38.00, and closed at $38.00. Trading volume was a total of 0 shares.

FPRX Historical Stock Prices By Date:

FPRX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into FPRX shares, starting with a $10,000 purchase of FPRX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 04/16/2021
Start price/share: $15.78
End price/share: $38.00
Dividends collected/share: $0.00
Total return: 140.81%
Average Annual Total Return: 13.40%
Starting investment: $10,000.00
Ending investment: $24,082.02
Years: 6.99
Date Open High Low Close Volume
04/12/2021 $37.91 $37.97 $37.91 $37.97 694.40K
04/13/2021 $37.96 $37.98 $37.94 $37.94 947.10K
04/14/2021 $37.96 $37.99 $37.94 $37.99 839.10K
04/15/2021 $37.99 $38.01 $37.95 $38.00 1.01M
04/16/2021 $38.00 $38.00 $38.00 $38.00 0
Five Prime Therapeutics is a clinical-stage biotechnology company focused on developing immune modulators and therapies for patients with solid tumor cancers. Co.'s primary focus is on developing immuno-oncology and targeted cancer therapies. Co.'s product candidate Bemarituzumab (FPA144) is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, and that induces antibody-dependent cellular cytotoxicity. Co.'s product candidate also include FPA150, an antibody that targets B7-H4 that Co. is studying in a clinical trial to treat patients with cancers that overexpress B7-H4; and FPT155, a soluble CD80 fusion protein that enhances co-stimulation of T cells through CD28.
Date Close
04/12/2021$37.97
04/13/2021$37.94
04/14/2021$37.99
04/15/2021$38.00
04/16/2021$38.00
FPRX is categorized under the Healthcare sector; below are some other companies in the same sector:

FRX Historical Stock Prices
FURX Historical Stock Prices
FVE Historical Stock Prices
GALE Historical Stock Prices
GALT Historical Stock Prices
GAP Historical Stock Prices
GB Historical Stock Prices
GBIM Historical Stock Prices
GBSN Historical Stock Prices
GBT Historical Stock Prices

Also explore: FPRX shares outstanding history

Email EnvelopeFree FPRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


FPRX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.